Bortezomib and Tuberculosis - a phase IV clinical study of FDA data

Summary:

Tuberculosis is reported as a side effect among people who take Bortezomib (bortezomib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Thalidomide, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Tuberculosis when taking Bortezomib. It is created by eHealthMe based on reports of 30,902 people who have side effects when taking Bortezomib from the FDA, and is updated regularly.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

What is Tuberculosis?

Tuberculosis (a bacterial infection by mycobacterium tuberculosis) is found to be associated with 628 drugs and 766 conditions by eHealthMe. Check the latest studies of Tuberculosis.

On Jul, 17, 2026

30,902 people reported to have side effects when taking Bortezomib.
Among them, 17 people (0.06%) have Tuberculosis.

Among these 17 people:

How long have people been on Bortezomib when they have Tuberculosis? *

What is the gender of people who have Tuberculosis when taking Bortezomib? *

female: 11.11 %
male: 88.89 %

What is the age of people who have Tuberculosis when taking Bortezomib? *

What are other drugs people take besides Bortezomib? *

What are other side effects people have besides Tuberculosis? *

Weakness: 5 people, 29.41%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 17.65%
Death: 3 people, 17.65%
Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 3 people, 17.65%
Multiple Myeloma (cancer of the plasma cells): 3 people, 17.65%
Urinary Tract Infection: 2 people, 11.76%
Pneumonia Bacterial (pneumonia associated with bacterial infection): 2 people, 11.76%
Therapeutic Response Decreased (less preventive response): 1 person, 5.88%
Drug Ineffective: 1 person, 5.88%
Herpes Simplex (herpes simplex is a common viral infection): 1 person, 5.88%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 13 people, 76.47%
Evans Syndrome (autoimmune disorder in which the body makes antibodies that destroy the red blood cells, platelets): 1 person, 5.88%
Disseminated Tuberculosis: 1 person, 5.88%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Bortezomib and have Tuberculosis?

- Check whether Tuberculosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bortezomib:

Bortezomib (30,912 reports)

Tuberculosis treatments and more:

Tuberculosis (26,436 reports)

Browse all side effects of Bortezomib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tuberculosis:

Tuberculosis (628 drugs)

Browse all the conditions that are associated with Tuberculosis:

Tuberculosis (766 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bortezomib (the active ingredients of Bortezomib) and Bortezomib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.